BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32930344)

  • 1. Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.
    Knuutila JS; Riihilä P; Kurki S; Nissinen L; Kähäri VM
    Acta Derm Venereol; 2020 Sep; 100(16):adv00266. PubMed ID: 32930344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
    Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
    JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
    Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
    JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of advanced cutaneous squamous cell carcinoma.
    Dessinioti C; Pitoulias M; Stratigos AJ
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
    Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
    J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
    Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
    Zuo S; Li X; Bao W; Li S
    Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.
    Riihilä P; Viiklepp K; Nissinen L; Farshchian M; Kallajoki M; Kivisaari A; Meri S; Peltonen J; Peltonen S; Kähäri VM
    Br J Dermatol; 2020 Mar; 182(3):658-670. PubMed ID: 31049937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
    Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
    Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients.
    Shibayama Y; Imafuku S
    J Dermatol; 2014 Dec; 41(12):1102-5. PubMed ID: 25385075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid growth rate is associated with poor prognosis in cutaneous squamous cell carcinoma.
    Cañueto J; Martín-Vallejo J; Cardeñoso-Álvarez E; Fernández-López E; Pérez-Losada J; Román-Curto C
    Clin Exp Dermatol; 2018 Dec; 43(8):876-882. PubMed ID: 29756221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
    Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
    JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
    Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
    JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
    de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
    Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
    Leiter U; Heppt MV; Steeb T; Alter M; Amaral T; Bauer A; Bechara FG; Becker JC; Breitbart EW; Breuninger H; Diepgen T; Dirschka T; Eigentler T; ElGammal AKS; Felcht M; Flaig MJ; Follmann M; Fritz K; Grabbe S; Greinert R; Gutzmer R; Hauschild A; Hillen U; Ihrler S; John SM; Kofler L; Koelbl O; Krause-Bergmann A; Kraywinkel K; Krohn S; Langer T; Loquai C; Löser CR; Mohr P; Nashan D; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Voelter-Mahlknecht S; Vordermark D; Weichenthal M; Welzel J; Wermker K; Wiegand S; Garbe C; Berking C
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1422-1433. PubMed ID: 37840404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of metastatic primary cutaneous squamous cell carcinoma utilizing artificial intelligence analysis of whole slide images.
    Knuutila JS; Riihilä P; Karlsson A; Tukiainen M; Talve L; Nissinen L; Kähäri VM
    Sci Rep; 2022 Jun; 12(1):9876. PubMed ID: 35701439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and clinical morbidity in high-risk head and neck cutaneous squamous cell carcinoma patients in Western Australia.
    Grover P; Flukes S; Jacques A; Leedman S; Lindsay A; White R; Friedland P; Gurfinkel R; Lim AM
    Intern Med J; 2022 Jun; 52(6):944-951. PubMed ID: 34800329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.